The biotech sector has enjoyed a solid week of gains indicative of the iShares Nasdaq Biotechnology Index ETF climbing over 3.5% in the past five trading sessions. “On a short-term basis, it is probably a little ahead of itself but, I like the names,” 55 Capital market strategist Max Wolff said on CNBC’s “Power Lunch” Friday afternoon.